RFA-Announcement of a Limited Competition for the Continuation of the Urinary Incontinence Treatment Network (UITN) [U01]

The summary for the RFA-Announcement of a Limited Competition for the Continuation of the Urinary Incontinence Treatment Network (UITN) [U01] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

RFA-Announcement of a Limited Competition for the Continuation of the Urinary Incontinence Treatment Network (UITN) [U01]: This is an announcement for a limited competition to solicit grant applications from investigators whose institutions are currently serving either as a Clinical Center or the Data Coordinating Center for the Urinary Incontinence Treatment Network (UITN). This Limited Competition will provide support for four years to Clinical Centers to continue recruitment, intervention, and follow-up of study participants enrolled in the Trial of Mid-Urethral Slings (TOMUS) and maintain long-term follow-up of women who completed the Stress Incontinence Surgical Treatment Efficacy Trial (SISTEr) and the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) clinical trials. This Limited Competition will also provide support for the Data Coordinating Center to continue to serve as the central repository to perform quality checks of the information received and to conduct analyses for TOMUS. In addition, the Data Coordinating Center will continue the follow-up studie! s of SISTEr and BE-DRI to perform final data analysis for these clinical trials.

Federal Grant Title:	RFA-Announcement of a Limited Competition for the Continuation of the Urinary Incontinence Treatment Network (UITN) [U01]
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-06-501
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.849
CFDA Descriptions:	Kidney Diseases, Urology and Hematology Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Mar 22, 2006
Posted Date:	Feb 23, 2006
Creation Date:	Feb 23, 2006
Archive Date:	Apr 21, 2006
Total Program Funding:	$4,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:	9
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Foreign institutions are not eligible to apply. You may submit an application if your organization has any of the following characteristics: Your institution received a Notice of Award (NoA) to participate either as a Clinical Center or the Data Coordinating Center for the Urinary Incontinence Treatment Network either under Request for Applications RFA-DK-99-001 or RFA-DK-01-018. Eligible Individuals Individuals who have enrolled patients in the two clinical trials conducted by the UITN (SISTEr and BE-DRI) during its first funding period (or in the case of the Data Coordinating Center, the institution which created the database, received data, and maintained the database for these clinical trials) are invited to submit grant applications to continue to participate in this network. The grant application should provide evidence that the work proposed is appropriate for the level of experience of the proposed Principal Investigator and for ! that of other researchers.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Investigations on Primary Immunodeficiency Diseases (R01); • Grants for Basic Research in Glomerular Diseases (R01); • Advances in Polycystic Kidney Disease (R01); • Ancillary Studies of Kidney Disease Accessing Information from Clinical Trials, Epidemiolo...; • Calcium Oxalate Stone Diseases (R01); • Research Grants for Clinical Studies of Kidney Diseases; • Chronic Prostatitis Collaborative Research Network (Cpcrn); • Frequent Hemodialysis Clinical Trials
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...